Montgomery RB - Search Results

1

Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.

Wright JL, Kwon EM, Ostrander EA, Montgomery RB, Lin DW, Vessella R, Stanford JL, Mostaghel EA. Wright JL, et al. Among authors: montgomery rb. Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):619-27. doi: 10.1158/1055-9965.EPI-10-1023. Epub 2011 Jan 25. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21266523 Free PMC article.

2

The increasing role of CAM in prostate cancer.

Zecha G, Lin DW, Montgomery RB. Zecha G, et al. Among authors: montgomery rb. JAAPA. 2004 Mar;17(3):37-40, 43-4. JAAPA. 2004. PMID: 15314882 Review. No abstract available.

3

Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells.

Montgomery RB, Bonham M, Nelson PS, Grim J, Makary E, Vessella R, Stahl WL. Montgomery RB, et al. Prostate. 2005 Oct 1;65(2):141-50. doi: 10.1002/pros.20246. Prostate. 2005. PMID: 15924336

4

Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.

Wright JL, Lin DW, Dewan P, Montgomery RB. Wright JL, et al. Among authors: montgomery rb. Int J Urol. 2005 Nov;12(11):1012-3. doi: 10.1111/j.1442-2042.2005.01196.x. Int J Urol. 2005. PMID: 16351664

5

Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.

Wu JD, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Plymate SR. Wu JD, et al. Among authors: montgomery rb. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6153-60. doi: 10.1158/1078-0432.CCR-06-0443. Clin Cancer Res. 2006. PMID: 17062692

6

The basic biochemistry and molecular events of hormone therapy.

Mostaghel EA, Montgomery RB, Lin DW. Mostaghel EA, et al. Among authors: montgomery rb. Curr Urol Rep. 2007 May;8(3):224-32. doi: 10.1007/s11934-007-0010-z. Curr Urol Rep. 2007. PMID: 17459272 Review.

7

Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.

Montgomery RB, Nelson PS, Lin D, Ryan CW, Garzotto M, Beer TM. Montgomery RB, et al. Cancer. 2007 Sep 1;110(5):996-1002. doi: 10.1002/cncr.22917. Cancer. 2007. PMID: 17639587 Free article. Clinical Trial.

8

An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer.

Plymate SR, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Wu JD. Plymate SR, et al. Among authors: montgomery rb. Clin Cancer Res. 2007 Nov 1;13(21):6429-39. doi: 10.1158/1078-0432.CCR-07-0648. Clin Cancer Res. 2007. PMID: 17975155

9

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS. Montgomery RB, et al. Cancer Res. 2008 Jun 1;68(11):4447-54. doi: 10.1158/0008-5472.CAN-08-0249. Cancer Res. 2008. PMID: 18519708 Free PMC article.

10

HE3235 inhibits growth of castration-resistant prostate cancer.

Koreckij TD, Trauger RJ, Montgomery RB, Pitts TE, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E. Koreckij TD, et al. Among authors: montgomery rb. Neoplasia. 2009 Nov;11(11):1216-25. doi: 10.1593/neo.09960. Neoplasia. 2009. PMID: 19881957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters